Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Revision of Antifungal Strategies Definitions for Invasive Fungal Infections (Proven/Probable/Possible) in Patients With Hematological Malignancies (REDEFI-SEIFEM)

NCT04024995 is registered in ClinicalTrials.gov with Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04024995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Revision of Antifungal Strategies Definitions for Invasive Fungal Infections (Proven/Probable/Possible) in Patients With Hematological Malignancies (REDEFI-SEIFEM)
Lead sponsor
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne
Phase
Observational
Overall status
Completed
Start date
September 1, 2019
Completion date
December 31, 2021
Enrollment
513 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.